Rumex hanus by. Extract Protects Against Chronic Alcohol-Induced Liver Injury in Mice

Area of Science:

• Hepatology
• Pharmacology
• Natural Product Chemistry

Background:

• Alcoholic liver disease (ALD) is a significant global health concern.
• Chronic alcohol consumption leads to severe liver damage, including inflammation and lipid metabolism disorders.
• Current treatments for ALD are limited, necessitating the exploration of novel therapeutic agents.

Purpose of the Study:

• To investigate the hepatoprotective effects of an extract from Rumex hanus by. (ERHB) against chronic alcoholic liver injury for the first time.
• To evaluate the impact of ERHB on liver function, lipid metabolism, and inflammation in an alcohol-induced liver injury model.
• To identify bioactive compounds within ERHB responsible for endotoxin antagonism.

Main Methods:

• ERHB was prepared using 70% ethanol extraction.
• In vitro assessment of ERHB's endotoxin antagonism rate.
• Animal experiments involving alcohol-induced liver injury model to assess hepatic function, lipid profiles, and inflammatory markers.
• Identification of seven compounds with endotoxin antagonistic activity in ERHB.

Main Results:

• ERHB exhibited an 88.94% endotoxin antagonism rate in vitro.
• ERHB significantly enhanced alcohol dehydrogenase and acetaldehyde dehydrogenase activities while reducing harmful enzyme levels (CYP450, ALP, AST, ALT).
• ERHB improved alcohol-induced dyslipidemia by regulating lipid metabolism and ameliorated liver injury by inhibiting endotoxin-induced inflammation.

Conclusions:

• ERHB demonstrates significant protective effects against alcoholic liver injury in animal models.
• ERHB's mechanisms involve promoting liver function, regulating lipid metabolism, and reducing inflammation.
• Further research confirming these findings in humans could establish ERHB as a valuable functional food supplement for ALD management.